For example, our preliminary data derived from analysis of reverse‐phase protein array (S‐Y Lee et al., unpublished) suggest that FAK is activated in dormant breast cancer cells—specifically upon treatment with Gedatolisib and doxorubicin. This evidence concerns the gene PTK2 and breast carcinoma.